Ilaris 150 mg/mL injection Images
Generic Name: canakinumab
This medication has been identified as Ilaris 150 mg/mL injection. It is supplied by Novartis Pharmaceuticals Corporation.
Ilaris is used in the treatment of Cryopyrin-Associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Familial Mediterranean Fever; Gout, Acute; Hyperimmunoglobulin D Syndrome and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Ilaris 150 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ilaris
- Generic Name
- canakinumab
- Strength
- 150 mg/mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0734
See also:
More about Ilaris (canakinumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.